Four 5-benzyl-1,3,4-thiadiazol-2-amine derivatives were synthesised from phenylacetic acid derivatives. The structures of the 5-benzyl-1,3,4-thiadiazole derivatives were characterised by NMR spectroscopy and X-ray crystallography. The acetylcholinesterase-inhibition activities were also tested. Among the four compounds, 5- (4-bromobenzyl)-1,3,4-thiadiazol-2-amine showed the best acetylcholinesterase-inhibition activity with an IC50 of 49.86 μM. The docking study performed with AUTODOCK demonstrated that this compound could interact with the catalytic active site of acetylcholinesterase.
BoresG.M., HugerF. P., PetkoW., MutlibA. E., CamachoF., RushD. K., SelkD. E., WolfV., KosleyR. W.Jr., DavisL., and VargasH. M., J. Pharmacol. Exp. Ther., 1996, 277, 728.
8.
ForetteF., AnandR., and GharabawiG., Eur. J. Neurol., 1999, 6, 423.
9.
ShiD.H., HuangW., LiC., LiuY. W., and WangS. F., Eur. J. Med. Chem., 2014, 75, 289.
10.
ShiD.H., YanZ. Q., ZhangL. N., WangY. R., JiangC. P., and WuJ. H., Arch. Pharm. Res., 2012, 35, 1645.
11.
EllmanG.L., CourtneyK. D., Andres andV.Jr., Feather-StoneR. M., Biochemical Pharmacology, 1961, 7, 88.
12.
SkrzypekA., MatysiakJ., NiewiadomyA., BajdaM., and SzymanskiP., Eur. J. Med. Chem., 2013, 62, 311.
13.
RydbergE.H., BrumshteinB., GreenblattH. M., WongD. M., ShayaD., WilliamsL. D., CarlierP. R., PangY.-P., SilmanI., and SussmanJ. L., J. Med. Chem., 2006, 49, 5491.
14.
Bruker, SMART (Version 5.628) and SAINT (Version 6.02).Bruker AXS Inc: Madison, WI, 1998.
15.
SheldrickG.M., SADABS. Program for empirical absorption correction of area detector.University of Göttingen: Göttingen, Germany, 1996.